Variable | No. | CD163+ macrophages counts in tumor nest | CD163+ macrophages counts in tumor stroma | ||||
---|---|---|---|---|---|---|---|
Low(≤6/HPF) | High(>6/HPF) | P | Low(≤8/HPF) | High(>8/HPF) | P | ||
Sex | Â | Â | Â | 0.037 | Â | Â | 0.846 |
 Male | 74 | 36 | 38 |  | 32 | 42 |  |
 Female | 53 | 16 | 37 |  | 22 | 31 |  |
Age (years) | Â | Â | Â | 0.874 | Â | Â | 0.674 |
 ≤50 | 26 | 11 | 15 |  | 12 | 14 |  |
 >50 | 101 | 41 | 60 |  | 42 | 59 |  |
Tumor location | Â | Â | Â | 0.389 | Â | Â | 0.057 |
 Tongue | 52 | 24 | 28 |  | 22 | 30 |  |
 Gingiva | 26 | 9 | 17 |  | 17 | 9 |  |
 Buccal mucosa | 31 | 9 | 22 |  | 7 | 24 |  |
 Lip | 4 | 3 | 1 |  | 2 | 2 |  |
 Floor of the mouth | 2 | 1 | 1 |  | 1 | 1 |  |
 Others | 12 | 6 | 6 |  | 5 | 7 |  |
Tumor size | Â | Â | Â | 0.921 | Â | Â | 0.335 |
 T1 | 21 | 7 | 14 |  | 7 | 14 |  |
 T2 | 68 | 31 | 37 |  | 30 | 38 |  |
 T3 | 26 | 8 | 18 |  | 9 | 17 |  |
 T4 | 12 | 6 | 6 |  | 8 | 4 |  |
Lymph node metastasis | Â | Â | Â | 0.200 | Â | Â | 0.889 |
 N0 | 72 | 33 | 39 |  | 31 | 41 |  |
 N (+) | 55 | 19 | 36 |  | 23 | 32 |  |
Metastasis | Â | Â | Â | 0.235 | Â | Â | 0.829 |
 M0 | 125 | 52 | 73 |  | 53 | 72 |  |
 M (+) | 2 | 0 | 2 |  | 1 | 1 |  |
Clinical stage | Â | Â | Â | 0.059 | Â | Â | 0.725 |
 I | 12 | 5 | 7 |  | 4 | 8 |  |
 II | 42 | 21 | 21 |  | 21 | 21 |  |
 III | 34 | 16 | 18 |  | 13 | 21 |  |
 IV | 39 | 10 | 29 |  | 16 | 23 |  |
Pathological grade | Â | Â | Â | 0.211 | Â | Â | 0.469 |
 I | 76 | 35 | 41 |  | 35 | 41 |  |
 II | 42 | 13 | 29 |  | 14 | 28 |  |
 III | 9 | 4 | 5 |  | 5 | 4 |  |
Recurrence | Â | Â | Â | 0.22 | Â | Â | 0.01 |
 No | 83 | 38 | 45 |  | 28 | 55 |  |
 Yes | 42 | 13 | 29 |  | 24 | 18 |  |
 Lost | 2 | 1 | 1 |  | 2 | 0 |  |
Follow-up | Â | Â | Â | 0.04 | Â | Â | 0.040 |
 Live | 91 | 43 | 48 |  | 34 | 57 |  |
 Dead | 33 | 8 | 25 |  | 17 | 16 |  |
 Lost | 3 | 1 | 2 |  | 3 | 0 |  |